Antiretroviral and Prophylactic Medication Calculator (ARVCalc)

Installation for Microsoft Windows®

1.      Install Epi Info from www.cdc.gov/epiinfo if it is not on the computer.  If you already have the file EpiInfoSetup3.2.2.exe, run it and answer all questions affirmatively. Be patient; it may take a little time to start installing.

2.      Download and Open or Run ARVCalc2.ZIP  from www.familyaids.org/informatics.htm.  If it is already on your computer, click on it, and unzip it to the directory C:\ARVCalc2\ according to the following instructions…

3.      Extract the files to location C:\ARVCalc2\  , leaving “Use folder names” checked if this option is offered. 

4.      With My Computer or Windows Explorer find a folder called C:\ARVCalc2\  with two files called “Shortcut to….” and “Enlace a ….” (for Spanish).  Drag one or both of these files to the desktop.

5.      Click the Shortcut  (or Enlace…) to run ARVCalc.  After a pause, a data entry screen should appear.

What is it?

ARVCalc is an Epi Info database and data-entry program that calculates pediatric doses of antiretrovirals and medications used for prophylaxis of opportunistic infections in infants and children living with HIV/AIDS.  The user enters information on height, weight, age, and--for infants—gestational status at birth, and then is able to choose from several first-line  treatment regimens and one second-line regimen, or alternatively, regimens for prevention of mother-to-child transmission for both mother and infant.  Recommended doses are calculated and presented, along with notes on methods of administration and precautions. 

 

The second page of the same form provides for prophylaxis of the opportunistic infections, including Pneumocystis jirovecii (formerly carinii) pneumonia (PCP), tuberculosis, and Mycobacterium avium complex (MAC), with preferred and alternative regimens for each.  Some notes are also provided on treatment of active PCP disease. 

Background

The regimens and doses are based on a DRAFT Guide for Pediatric Care of Patients with HIV / AIDS prepared by the Ministry of Health of the Dominican Republic and revised by one of us, but not yet approved for general use.  This guide is, in turn, based on CDC Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection MMWR April 17, 1998 / 47(RR-4);1-31, Treating Opportunistic Infections Among HIV-Exposed and Infected Children   Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America, and the New York State Department of Health AIDS Institute Pediatric and Adolescent HIV Guidelines, Pediatric Antiretroviral Therapy ( http://www.hivguidelines.org/public_html/p-arv/p-arv-appa.htm ).  It is used here only to illustrate how ARV protocols can be expressed in check code within an Epi Info form, and it is assumed that other users may prepare their own version.  Two versions are provided, one in Spanish and the other in English, with compatible databases.

Intended use

In our clinic, we enter data once for each child on ARVs and then print the page containing the calculations as a permanent record to place in the chart.  We suspect that very few physicians will enter the data directly, but that a nurse or other central person might do the entry and pass the printed results to the physician in the chart.  As the child “outgrows”  his or her dose(s), which may be in a 6-8 weeks in infancy, and in months to a year in older children, the data will be reentered, and new doses provided.  For educational purposes, however, physicians who do not regularly administer pediatric ARV therapy may find it instructive to experiment with the various regimens in the program.

Is it Useful for Adults? 

The guidelines and programs were developed for pediatric use.  Most of the doses, however, have a maximum, which is the adult dose.  We would appreciate hearing from experts in use of ARV’s for adults concerning what changes would be necessary to be able to use a single program for both adults and children. 

Working with ARVCalc

To see patients already entered, use the arrow buttons in the lower left panel to move back to previous records.  To enter a new patient, click on the NEW button.  After entering a patient’s data, choose a regimen by clicking, and experiment with the calculations.  To calculate regimens for prophylaxis of opportunistic infections, click Page 2 in the upper left panel, and work with the choices offered.  Note that less common opportunistic infections and treatment of active tuberculosis are not covered; more complete, printed protocols should be consulted for further detail.

Warning and Plea for Input

NOTE THAT THIS IS A DRAFT OR BETA COPY, and should not be relied upon without checking against other sources.  Feel free to enlist help in evaluating it, but please do not distribute it for general use until it is further developed.  It is free of copyright or other restriction.  Please let us know if bugs or inconsistencies or serious conflicts with other protocols are encountered.  For those who are familiar with Epi Info or who wish to experiment, it is easy to modify the check-code using the MakeView program.  We would be grateful to know of improvements that you make or recommend making.  At the moment, CD4 counts and hemoglobins may be entered in the form, but they are not used in the logic of calculations or warnings.  This could be implemented with additional check code in the future.

 

Please send feedback, suggestions and corrections to:

 

Andrew G. Dean, MD, MPH

Agdean9@hotmail.com

Consuelo M. Beck-Sagué, MD

rocknrollmd@hotmail.com